Inhibitory effects of histone deacetylase inhibitor depsipeptide on benzo(a)pyrene-and cyclophosphamide-induced genotoxicity in Swiss albino mice

International Journal of Toxicology

Volumn 26, Issue 1, 2007, Pages 47-50

  Kumar, Radhakrishnan Vinodh ^a   Mu, Park Chung ^b   Ravikumar, Vilwanathan ^c   Devaki, Thiruvengadam ^a  

^a UNIVERSITY OF MADRAS   (India)

^b Inje University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Benzo(a)pyrene; Cyclophosphamide; Depsipeptide; FK228; Genotoxicity; Micronucleus Test

Indexed keywords

BENZO[A]PYRENE; CYCLOPHOSPHAMIDE; DEPSIPEPTIDE; FR 901228; HISTONE DEACETYLASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CHROMOSOME DAMAGE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GENOTOXICITY; MALE; MICRONUCLEUS; MOUSE; MOUSE STRAIN; NONHUMAN;

ANIMALS; ANTIMUTAGENIC AGENTS; BENZO(A)PYRENE; CHROMOBACTERIUM; CYCLOPHOSPHAMIDE; DEPSIPEPTIDES; DNA DAMAGE; HISTONE DEACETYLASES; MALE; MICE; MICRONUCLEUS TESTS;

MUS;

EID: 33847685224     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810601120111     Document Type: Article

References (26)

1. Abraham, S. K., S. P. Singh, and P. C. Kesavan. 1998. In vivo antigenotoxic effects of dietary agents and beverages co-administered with urethane: assessment of the role of glutathione S-transferase activity. Mutat. Res 413:103-110.
2. Baker, B. S., A. T. C. Carpenter, M. S. Esposito, R. E. Esposito, and L. Sandler. 1976. The genetic control of meiosis. Annu. Rev. Genet. 10:53-134.
3. Chan, K. K., R. Bakhtiar, and C. Jiang. 1997. Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS Invest. New Drugs. 15:195-206.
4. Chatterjee, I. B., C. K. Mukhopadhyay, and M. K. Ghosh. 1995. Vitamin C: A potential saviour against free radical induced oxidative damage. Curr. Sci. 69:747-751.
5. Dhuley, J. N., P. H. Raman, M. Mujumdar, and S. R. Naik. 1993. Inhibition of lipid peroxidation by piperine during experimental inflammation in rats. Indian J. Exp. Biol. 31:443-445.
6. Duncan, D. B. 1955. Multiple range and multiple F test. Biometrics 11:1-42.
7. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription: Histone acetylation in chromatin structure and transcription, Nature 389:349-352.
8. Jassim, A. D., V. L. Sparins., and L. W. Wattenberg. 1990. Long term effects of benzo(a)pyrene on the activity of NAD(P)H: Quinone reductase in the fore stomach and glandular stomach of ICR/Ha mice. Cancer Res. 50:2064-2067.
9. Klaassen, C. 1996. Genetic toxicology. In: Casarett and Doull's toxicology - The basic science of poisons, 5th ed., ed. C. D. Klaassen, 269. New York: McGraw-Hill.
10. Kim, H. S., S. J. Kawack, and B. M. Lee. 2000. Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrene-quinones in the blood of rats treated with benzo[a]pyrene. Chem. -Biol. Interact. 127:139-150.
11. Morse, M. A., and G. D. Stoner. 1993. Cancer chemoprevention: Principles and prospects. Carcinogenesis 14:1737-1746.
12. Nervi, C., U. Borello, F. Fazi, V. Buffa, P. G. Pelicci and G. Cossu. 2001. Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. Cancer Res.61:1247-1249.
13. Piekarz, R. L., R. Robey., V. Sandor, S. Bakke, W. H. Wilson, L. Dahmous, D. M. Kingma, M. L. Turner, R. Altemus, and S. E. Bates. 2001. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and coetaneous T-cell lymphoma: A case report. Blood 98:2865-2868.
14. Ramel, C., U. K Alekperov, B. N. Ames, T. Kada, and L. W. Wattenberg. 1986. Inhibitors of mutagenesis and their relevance to carcinogenesis. Mutat. Res. 168:47-65.
15. Reen, R. K., S. F. Roesch, F. Kiefer, F. J. Weibel, and J. Sigh. 1996. Piperine impairs cytochrome P4501A1 activity by direct interaction with the enzyme and not by down regulation of CYP1A1 gene expression in the rat hepatoma 5L cell line. Biochem. Biophys. Res. Commun. 218:562-569.
16. Renner, H. W. 1990. In vivo effects of single or combined dietary antimutagens on mutagen-induced chromosomal aberrations. Mutat. Res. 44:185-188.
17. Rogers, A. E., S. H. Zeisel, and Groopman. 1993. Diet and carcinogenesis. Carcinogenesis 14:2205-2217.
18. Salamone, M. F., and J. A. Heddle. 1983. The bone marrow micronucleus assay: rationale for a revised protocol. In: Chemical mutagens, 8, ed. F. J. de Serres, 111-149. New York: Plenum.
19. Sasakawa, Y., Y. Naoe, T. Inoue, T. Sasakawa, M. Matsuo, T. Manda and S. Mutoh. 2002. Effects of FK228, a novel histone deacetylase inhibitors, on human lymphoma U-937 cells in vitro and in vivo. Biochem. Pharmacol. 64:1079-1090.
20. Sandor, V., S. Bakke, and R. W. Robey, M. H. Kang, M. V. Blagosklonny, J. Bender, R. Brooks, R. L. Piekarz, E. Tucker, W. D. Figg, K. K. Chan, B. Goldspiel, A.T. Fojo, S. P. Balcerzak, and S. E. Bates. 2003. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin. Cancer Res. 8:718-728.
21. Schmid, W. 1975.The micronucleus test. Mutat. Res. 31:9-15.
22. Shigematsu, N., H. Ueda, S. Takase, H. Tanaka, K. Yamamoto, and T. Tada. 1994. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, II; structure determination. J. Antibiot. 47:311-314.
23. Ueda, H., T. Manda, S. Matsumoto, S. Mukumoto, F. Nishigaki, I. Kawamura, and K. Shimomura. 1994a. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, III; Antitumor activities on experimental tumors in mice. J. Antibiot. 47:315-323.
24. Ueda, H., H. Nakajima , Y. Hori, T. Fujita, M. Nishimura, T. Goto, and M. Okuhara. 1994b. FR901228, a novel antitumor bicyclic depsipeptide produced by Chomobacterium violaceum no. 968, I; taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J. Antibiot. 47:301-310.
25. Willems, M. I., and W. K. De Raat. 1985. Mutagenicity of urine and faeces after treatment of rats with known genotoxins. Carcinogenesis 6:967-976.
26. Yoshida, M., and S. Horinouchi. 1999. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export. Ann. N. Y. Acad. Sci. 886:23-36.